methotrexate tablet
1 INDICATIONS AND USAGE Methotrexate tablets are a dihydrofolate reductase inhibitor indicated for the: Treatment of adults and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. ( 1.1 ) Treatment of adults with mycosis fungoides. ( 1.1 ) Treatment of adults with relapsed or refractory non-Hodgkin lymphoma as part of a metronomic combination regimen. ( 1.1 ) Treatment of adults with rheumatoid arthritis. ( 1.2 ) Treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA). ( 1.3 ) Treatment of adults with severe psoriasis. ( 1.4 ) 1.1 Neoplastic Diseases Methotrexate tablets are indicated for the: treatment of adults and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. treatment of adults with mycosis fungoides (cutaneous T-cell lymphoma) as a single agent or as part of a combination chemotherapy regimen. treatment of adults with relapsed or refractory non-Hodgkin lymphomas as part of a metronomic combination chemotherapy regimen. 1.2 rheumatoid arthritis Methotrexate tablets are indicated for the treatment of adults with rheumatoid arthritis. 1.3 Polyarticular Juvenile Idiopathic Arthritis Methotrexate tablets are indicated for the treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA). 1.4 Psoriasis Methotrexate tablets are indicated for the treatment of adults with severe psoriasis.
amneal pharmaceuticals ny llc
ROUND YELLOW A 1
A 1 ROUND YELLOW
Related Pills
methotrexate tablet
amneal pharmaceuticals ny llc
hydrochlorothiazide 12.5 mg
Heritage Pharmaceuticals Inc. d/b/a Avet Phar
bupropion hydrochloride tablet film coated extended release
par pharmaceutical, inc.
Naproxen Naproxen 500 MG Oral Tablet
Teva Pharmaceuticals USA Inc
Sertraline 100 mg
McKesson Packaging Services Business Unit of
meloxicam 15 mg
Cipla USA Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
METHOTREXATE Tablets USP, 2.5 mg , are supplied as round, biconvex, yellow tablets, scored in half on one side, engraved with “A” above the score and “1” below. They are available as follows: Bottles of 36: NDC 69238-1423-6 Bottles of 100: NDC 69238-1423-1 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
METHOTREXATE tablets, USP is a cytotoxic drug. Follow applicable special handling and disposal procedures. 1
More pills like ROUND A 1